Agilent Technologies, Inc. $A Shares Purchased by Noesis Capital Mangement Corp

Noesis Capital Mangement Corp lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 5.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 126,929 shares of the medical research company’s stock after buying an additional 6,802 shares during the period. Agilent Technologies accounts for approximately 2.5% of Noesis Capital Mangement Corp’s portfolio, making the stock its 15th largest holding. Noesis Capital Mangement Corp’s holdings in Agilent Technologies were worth $16,291,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Resona Asset Management Co. Ltd. raised its holdings in Agilent Technologies by 6.2% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after acquiring an additional 5,767 shares during the period. TrueMark Investments LLC bought a new position in Agilent Technologies during the 2nd quarter worth $1,999,000. Nuance Investments LLC raised its stake in Agilent Technologies by 13.5% in the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock valued at $9,523,000 after purchasing an additional 9,628 shares in the last quarter. Fenimore Asset Management Inc lifted its stake in Agilent Technologies by 2.7% during the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after purchasing an additional 4,823 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Agilent Technologies by 472.5% during the second quarter. Arrowstreet Capital Limited Partnership now owns 221,993 shares of the medical research company’s stock worth $26,197,000 after purchasing an additional 183,220 shares during the period.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,401 shares of company stock valued at $2,468,962 in the last 90 days.

Analyst Ratings Changes

Several equities analysts recently weighed in on A shares. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. Evercore ISI raised Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price target for the company from $155.00 to $160.00 in a research report on Monday. Bank of America raised their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Finally, Morgan Stanley initiated coverage on shares of Agilent Technologies in a research report on Tuesday, December 2nd. They issued an “overweight” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $163.31.

Agilent Technologies Price Performance

Shares of A opened at $147.81 on Thursday. The stock’s 50 day moving average is $144.46 and its two-hundred day moving average is $132.13. The firm has a market capitalization of $41.90 billion, a PE ratio of 32.34, a P/E/G ratio of 4.29 and a beta of 1.29. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same quarter in the prior year, the company posted $1.46 EPS. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.